PharmaZell gladly informs that we have received US-FDAs approval for our DMF-Type-II for our Product Teriflunomide.
The construction of our new buildings in gropello continues apace.
We are pleased to announce that PharmaZell(India)Private Limited has been awarded EcoVadis Silver Medal in Recognition for Sustainability Performance. This Recognition places our company among the top 25 percent of companies assessed by EcoVadis.
New expansion of fully automated and dedicated Production facility for Mesalamine has picked up its momentum at Visakhapatnam site. It is targeted to start the production in October-2021. Impact of COVID-19 lead to few disturbances for 2-3 weeks, however there are adeuqate buffer time in plan to mitigate potential delays. Majority of the equipment are
20 April 2021, Gropello. Farmabios Spa, part of the PharmaZell Group, is pleased to announce it has received validation from the European Commission (“EC”), and European Food Safety Authority (“EFSA”) for the dossier on synthetic CBD as a Novel Food.
FarmaBios successfully completed the certification process in accordance with the ISO 45001:2018 standards. The new certificate is the last achievement of the list together with ISO 9001:2015 and ISO 14001:2015. With this certificate valid until 28th July 2023, FarmaBios presents objective evidence for the commitment to provide high quality and to works on continuous improvement
Vizag Unit has got approval from Board to expand 5ASA for one more separate 180 TPA manufacturing facility. Site clearance is given and the Civil work inaugural was organised on 23rd of July’2020. Site levelling is done for entire work area. All the possible measures have been taken towards Safety. The civil work for the
We are very glad to announce that AIFA renewed the complete GMP certificate for Farmabios on July 7th 2020 SpA facility